Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1953 (LINC01953) is a member of the long intergenic non-coding RNA (lincRNA) family—transcripts longer than 200 nucleotides that do not overlap protein-coding regions and are generally not translated into proteins. LINC01953 is cataloged in reference gene databases, but, to date, there are no published mechanistic studies, known interacting drugs, or established roles in major human diseases. lincRNAs, as a group, can regulate chromatin structure, influence transcription and translation, and participate in a variety of cellular processes; however, the specific biological role and clinical relevance of LINC01953 remain undetermined. If more specific mechanistic or disease relevance for LINC01953 is needed, this would require further literature or specialized database review, as no association is reported in current major lncRNA or GWAS catalogs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1953 (LINC01953).